Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial
2021 · Annals of the Rheumatic Diseases · 100 citations
https://doi.org/10.1136/annrheumdis-2021-221048
R
Ricardo Blanco
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.1K
Papers
19.7K
Citations
72
h-index
359
i10-index
Ricardo Blanco is an academic researcher from Universidad de Cantabria. The author has contributed to research in topics: Systemic Lupus Erythematosus Research & Vasculitis and related conditions & Rheumatoid Arthritis Research and Therapies. The author has an h-index of 72, co-authored 915 publications.
ORCID: 0000-0003-2344-2285Papers by this author
worksGenetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review
2018 · Autoimmunity Reviews · 98 citations
https://doi.org/10.1016/j.autrev.2017.11.024
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy
2017 · Scientific Reports · 72 citations
https://doi.org/10.1038/srep43953
The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases
2023 · Frontiers in Immunology · 68 citations
https://doi.org/10.3389/fimmu.2023.1191782
Single-organ cutaneous small-vessel vasculitis according to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides: a study of 60 patients from a series of 766 cutaneous vasculitis cases
2014 · Lara D. Veeken · 59 citations
https://doi.org/10.1093/rheumatology/keu295
A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis
2017 · Scientific Reports · 58 citations
https://doi.org/10.1038/s41598-017-03915-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat